KCA 23 -60 Capsules

60 Capsules Small

500mg /capsule

Price : 298 $ USD

Another size

45 Capsules Big

775mg / capsule

Price : 335 $ USD

Composition :

Urtica dioica / roots
Pimpinella anisum / seeds
Cucurbita pepo / seeds
Populus alba / buds
Cinnamomum aromaticum / bark

KL CA 23 :

A product based on natural medicinal plants, belonging to the third generation of medicines, without side effects. It is used as an adjuvant in the treatment of prostate cancer.

Indications :

– Prostate, urinary tract, and bladder cancer.
– Benign and malignant tumors of the prostate.
– Side effects of oncological treatments (radiotherapy, chemotherapy, hormone therapy).

Prostate :

The prostate is a walnut-sized gland in the male reproductive system that contributes to the production of seminal fluid, essential for sperm viability.

Prostate cancer ranks third among the most common cancers worldwide. In the early stage, symptoms are similar to those of benign prostatic hyperplasia, including frequent urination (pollakiuria), painful urination (dysuria), and blood in the urine (hematuria).

The progression of prostate disease is often slow and silent, but once it reaches an advanced stage, treatment becomes difficult and prolonged. Periodic screening tests are recommended from a certain age.

Risk factors:
– Age: severity increases with age.
– Race: Black men are more likely to develop the disease than White men.
– Family history: especially if genes for breast or prostate cancer are present in close relatives.
– Metastases: may affect the urinary system, kidneys, or bones.
– Possible consequences: difficulty urinating, impotence, lower limb edema, lower back and sacroiliac pain, bone pain.

KL CA 23 Benefits :

– A potent antioxidant with immunostimulatory properties, owing to its high content of proanthocyanidins and cinnamaldehydes.
– Prevents the binding of dihydrotestosterone (DHT) to androgen receptors expressed by tumor cells.
– Inhibits the cerebral synthesis of DCX proteins, whose expression is significantly elevated in prostate cancer.
– Suppresses prostate tumor angiogenesis through inhibition of vascular endothelial growth factor (VEGF), thereby depriving cancer cells of essential metabolic support and promoting subsequent tumor regression.
– Regulates the activity of 5-alpha-reductase, the enzyme responsible for converting testosterone into dihydrotestosterone, a key factor in prostate development, thus helping to prevent prostatic hypertrophy.
– Activates immune checkpoint inhibitory antibodies, restoring immune system function and enabling targeted immune-mediated destruction of prostate cancer cells.
– Balances the production of pro-inflammatory cytokines and supports optimal hormonal, urinary, and sexual function of the prostate.